Please assess the completion status of the following clinical trial:

Trial Title: Quickstart of Nexplanon® at Medical Abortion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women opting for medical abortion and post abortion Nexplanon~* no contraindicated to medical abortion or Nexplanon (according to the SMPc) gestational length up to and including 63 days (determined with ultrasonography)~* able and willing to provide informed consent~Exclusion Criteria:~* unwilling to participate,~* unable to communicate in Swedish and English and~* minors (i.e. women \< 18 years of age),~* contraindications to Nexplanon®~* women with pathological pregnancies

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Etonorgestrel and mifepristone (Type: EXPERIMENTAL): Quickstart, insertion of Nexplanon on the day of mifepristone in medical abortion
- mifepristone (Type: ACTIVE_COMPARATOR): Mifepristone on day 1. Nexplanon insertion at 3 weeks FU after the medical abortion

Based on this trial design, predict the completion outcome and termination type (if applicable).